Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial
Hoffmann et al., eBioMedicine, doi:10.1016/j.ebiom.2025.105613
https://c19early.org/hoffmann2.html